In last trading session, Neuronetics Inc (NASDAQ:STIM) saw 0.52 million shares changing hands with its beta currently measuring 1.77. Company’s recent per share price level of $3.66 trading at -$0.17 or -4.44% at ring of the bell on the day assigns it a market valuation of $241.98M. That closing price of STIM’s stock is at a discount of -61.75% from its 52-week high price of $5.92 and is indicating a premium of 85.79% from its 52-week low price of $0.52. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.79 million shares which gives us an average trading volume of 843.52K if we extend that period to 3-months.
For Neuronetics Inc (STIM), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.08 in the current quarter.
Neuronetics Inc (NASDAQ:STIM) trade information
Neuronetics Inc’s shares saw a change of 83.00% in year-to-date performance and have moved 2.52% in past 5-day. Neuronetics Inc (NASDAQ:STIM) showed a performance of 4.87% in past 30-days. Number of shares sold short was 3.11 million shares which calculate 5.27 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 8 to the stock, which implies a rise of 54.25% to its current value. Analysts have been projecting 8 as a low price target for the stock while placing it at a high target of 8. It follows that stock’s current price would drop -118.58% in reaching the projected high whereas dropping to the targeted low would mean a loss of -118.58% for stock’s current value.
Neuronetics Inc (STIM) estimates and forecasts
This year revenue growth is estimated to rise 102.24% from the last financial year’s standing.
3 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 36.8M for the same. And 3 analysts are in estimates of company making revenue of 38.31M in the next quarter. Company posted 16.45M and 18.53M of sales in current and next quarters respectively a year earlier. Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 2.71% during past 5 years.
Neuronetics Inc (NASDAQ:STIM)’s Major holders
Insiders are in possession of 9.17% of company’s total shares while institution are holding 62.80 percent of that, with stock having share float percentage of 69.15%. Investors also watch the number of corporate investors in a company very closely, which is 62.80% institutions for Neuronetics Inc that are currently holding shares of the company. ARCHON CAPITAL MANAGEMENT LLC is the top institutional holder at STIM for having 2.47 million shares of worth $4.45 million. And as of 2024-06-30, it was holding 8.23 of the company’s outstanding shares.
The second largest institutional holder is CANNELL CAPITAL LLC, which was holding about 2.38 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.9239 of outstanding shares, having a total worth of $4.29 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025, the former fund manager was holding 1.81 shares of worth $6.61 million or 2.73% of the total outstanding shares. The later fund manager was in possession of 429.32 shares on Mar 31, 2025, making its stake of worth around $1.57 million in the company or a holder of 0.65% of company’s stock.
